IL1B and Alzheimer disease: A significant increase of serum IL-1β has been also considered as a biomarker for the diseases [20,56,57,59,62,66,67] but a number of investigations testify against the difference in serum IL-1β between patients with PD or AD and healthy donors [61,65].